Literature DB >> 15452830

Differential localization and expression of the Cdk9 42k and 55k isoforms.

Hongbing Liu1, Christine H Herrmann.   

Abstract

Cdk9, a member of the cyclin-dependent kinase family, is the catalytic subunit of P-TEFb, a protein kinase complex that stimulates transcriptional elongation. Cdk9, complexed with its regulatory partner cyclin T1, serves as the cellular mediator of the transactivation function of the HIV Tat protein. There are two known isoforms of Cdk9: a 42 kDa protein (42k, originally identified as PITALRE) and a more recently identified 55 kDa form (55k). To investigate possible functional differences between the two isoforms, we examined their kinase activities, their subcellular distributions, and their expression levels in primary cells relevant to HIV infection. Both isoforms were found to hyper-phosphorylate the carboxyl-terminal domain of the largest subunit of RNA polymerase II and displayed identical phosphorylation patterns with 144 peptide substrates. Epitope-tagged transiently-expressed Cdk9 42k localized diffusely in the nucleoplasm, while Cdk9 55k accumulated in the nucleolus. In primary undifferentiated monocytes, Cdk9 55k expression was not detected although 42k was present at high levels; however, 55k expression was induced upon macrophage differentiation. In primary lymphocytes, the levels of 55k decreased or remained steady following activation, while the levels of 42k increased. The promoter for 42k was significantly stronger than that of 55k in HeLa cells, and only the 42k promoter was responsive to activation signals in primary lymphocytes. These results indicate that expression of the 42k and 55k isoforms is differentially regulated and suggest that functional differences between the 42k and 55k isoforms of Cdk9 are likely to depend on access to substrates based on their differential subcellular localization and expression patterns. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15452830     DOI: 10.1002/jcp.20224

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  34 in total

1.  Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4(+) T lymphocytes.

Authors:  Rajesh Ramakrishnan; Eugene C Dow; Andrew P Rice
Journal:  J Leukoc Biol       Date:  2009-09-10       Impact factor: 4.962

2.  Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.

Authors:  Rajesh Ramakrishnan; Andrew P Rice
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

3.  CDK9-mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery.

Authors:  Prisca Brauns-Schubert; Florian Schubert; Manuela Wissler; Martina Weiss; Lisa Schlicher; Simon Bessler; Mariam Safavi; Cornelius Miething; Christoph Borner; Tilman Brummer; Ulrich Maurer
Journal:  EMBO Rep       Date:  2018-01-15       Impact factor: 8.807

Review 4.  Cyclin-dependent kinases as therapeutic targets for HIV-1 infection.

Authors:  Andrew P Rice
Journal:  Expert Opin Ther Targets       Date:  2016-11-10       Impact factor: 6.902

5.  Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.

Authors:  Md Saha Jamaluddin; Pei-Wen Hu; Yih Jan; Edward B Siwak; Andrew P Rice
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

6.  Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.

Authors:  Abdelkader Khiati; Olivier Chaloin; Sylviane Muller; Marc Tardieu; Philippe Horellou
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

7.  Discovery of cell compartment specific protein-protein interactions using affinity purification combined with tandem mass spectrometry.

Authors:  Mathieu Lavallée-Adam; Justine Rousseau; Céline Domecq; Annie Bouchard; Diane Forget; Denis Faubert; Mathieu Blanchette; Benoit Coulombe
Journal:  J Proteome Res       Date:  2012-12-04       Impact factor: 4.466

8.  Pivotal role of cardiac lineage protein-1 (CLP-1) in transcriptional elongation factor P-TEFb complex formation in cardiac hypertrophy.

Authors:  Jorge Espinoza-Derout; Michael Wagner; Katayoun Shahmiri; Eduardo Mascareno; Brahim Chaqour; M A Q Siddiqui
Journal:  Cardiovasc Res       Date:  2007-03-28       Impact factor: 10.787

9.  Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.

Authors:  S-W Grace Cheng; Michael A Kuzyk; Annie Moradian; Taka-Aki Ichu; Vicky C-D Chang; Jerry F Tien; Sarah E Vollett; Malachi Griffith; Marco A Marra; Gregg B Morin
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.